Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced

Status Not yet recruiting

Clinical Trial Summary

The investigators intend to conduct a randomized controlled study to find if combining HIPEC (hyperthermic intraperitoneal perfusion chemotherapy) with post-neoadjuvant chemotherapy D2 resection could improve survival for patients with advanced gastric cancer, while comparing with the traditional approach of D2 resection after neoadjuvant chemotherapy.

Clinical Trial Description

Gastric cancer, as the second common malignant tumors in china, is marked by its poor prognosis and high recurrent rate. Although R0 resection could be achieved in most advanced gastric cancer(AGC) patients without metastasis, age-standardized 5-years survival rate was no more than 27.4%. Peritoneal metastasis accounts for 50% of the recurrent case and remain to be the most fatal recurrence pattern.

Hyperthermic intraperitoneal perfusion chemotherapy ( HIPEC ), has been proved as one of the most efficient approach against peritoneal carcinomatosis from gastric cancer and recommended in the guideline for gastric cancer published by the health committee of china. However, its role as prophylactic treatment after curative has never been determined. HIPEC works by delivering heat and cytotoxic drug to the cancer cell and is more effective on the tumor with small size. As present study suggest that Peritoneal metastasis is related to lymph node dissection during surgery while opening lymphatic channels and spreading viable cancer cells into the peritoneal cavity, HIPEC might be a reasonable approach to destroy the remaining cancer cells after curative surgery. Thus this research aim to explore the efficacy and safety of combining HIPEC (hyperthermic intraperitoneal perfusion chemotherapy) with post-neoadjuvant chemotherapy D2 resection. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02960061
Study type	Interventional
Source	Sixth Affiliated Hospital, Sun Yat-sen University
Contact	Hua-She Wang, PhD
Phone	+8613824468573
Email	angelwhs@sohu.com
Status	Not yet recruiting
Phase	Phase 3
Start date	November 2016
Completion date	December 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01952184` - Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.	N/A
Completed	`NCT00993343` - Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation	Phase 3
Recruiting	`NCT04808466` - Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy	Phase 2
Not yet recruiting	`NCT04845490` - Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy	Phase 2
Recruiting	`NCT03291275` - Survival Outcomes of Uterine Malignancies in Chinese Population	N/A
Recruiting	`NCT05720858` - Telerehabilitation in Survival Breast Cancer Patients	N/A
Completed	`NCT03351920` - Ventilation's Parameters Applied in Emergency Medicine. A Prospective Observational Study
Not yet recruiting	`NCT06147180` - Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
Recruiting	`NCT04472403` - Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma
Recruiting	`NCT03739944` - Different Surgical Approaches in Patients of Early-stage Cervical Cancer	Phase 3
Recruiting	`NCT03738969` - Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer
Completed	`NCT03134807` - The Very Old Intensive Care Patient: A Multinational Prospective Observation Study
Completed	`NCT03084809` - Chemotherapy Combined With CIK Treating Colon Cancer	Phase 4
Completed	`NCT03642041` - Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients
Recruiting	`NCT04351308` - Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma	Phase 2
Recruiting	`NCT03920033` - Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy	N/A
Recruiting	`NCT05540119` - Swedish Oesophago-Gastric Study
Completed	`NCT04519450` - Ultrasound of Accessory Respiratory Muscles
Active, not recruiting	`NCT01835821` - Clinical Study of Porcelain-fused and IPS e.Max CAD Crowns	N/A
Completed	`NCT00565188` - Application of ATP Infusions in Palliative Home Care	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer — HIPEC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms